The Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan has been awarded a $24 million grant ...

This is Uganda's sixth outbreak of Ebola Sudan, which causes severe hemorrhagic fever disease with a case fatality rate of up to 50%. No licensed vaccines or therapeutics are available for Ebola Sudan ...

Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing ...

“The clever design works by presenting fragments of several coronaviruses together to potentially induce a strong immune ...

WHO and partners have immediately boosted their support to the Ugandan government's response to an outbreak of Sudan virus disease outbreak (SVD, part of the Ebola family), including by facilitating ...

The wizards at the Vaccine and Infectious Disease Organization, more commonly known as VIDO and located on the University of ...

VIDO's funding flows from Norwegian-based Coalition for Epidemic Preparedness Innovations (CEPI) into its ongoing development of its pan-sarbecovirus vaccine. Dr. Nicole Lurie, Executive ...

"When a pandemic strikes, saving lives hinges on rapid vaccine development and equitable access" -- David Agunlofi, Programme and Communications Associate at Options ConsultancyLassa fever, a viral ...

The World Health Organization (WHO) and its partners have significantly intensified their support for Uganda's response to the ongoing outbreak of Sudan virus disease (SVD), a deadly illness in the ...

Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidemic Preparedness Innovations (CEPI), in order to advance the development of Vaxxas’ needle-free ...